Step 3 Notes

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 4
At a glance
Powered by AI
Some key takeaways from the notes include bile-salt induced diarrhea, hemoptysis differential diagnosis, acute COPD and asthma exacerbation management, meningococcal meningitis prophylaxis, HIV lipodystrophy vs Cushing's syndrome, and rapid sequence intubation procedures.

The most frequent single-item predictors of severity of acute pancreatitis include hematocrit >44% on admission, BUN >20 on admission, AST > 250, BMI >30, serum lipase > 1000 in adults, and increases in BUN on serial measurements. Symptoms include abdominal pain, nausea, vomiting.

The Ranson criteria and APACHE II score are used to assess severity of acute pancreatitis. The Ranson criteria involves 11 criteria that must be calculated over 48 hours and has been shown to be a poor predictor. The APACHE II score and other criteria like SIRS and BISAP have better predictive characteristics.

UWorld Step 3 Notes

- Bile-salt induced diarrhea


o 5-10% of patients post cholecystectomy and patients with short bowel syndrome
o Secondary bile acids cause colonic stimulation when present in excess amounts
o Tx: bile salt-binding resins (eg cholestyramine)
- Hemoptysis 2/2 ??
o DDx: Acute bronchitis, trauma, infectious etiology, PE, cancer, cardiac (acute pulmonary
edema or hemoptysis)
o FSOM: CXR
 Clues to specific causes (malignancy, infection, heart disease)
- Acute COPD exacerbation
o Signs and symptoms
 Productive cough w/ green-yellow sputum, dyspnea, wheezing, hx of COPD
o FSOM if increased sputum  glucocorticoids, inhaled bronchodilators
 No clear benefit w/ expectorants (N-acetylcysteine) or systemic bronchodilators
(eg. Theophylline)
 Acute Bronchitis  NO ABX --- (if otherwise healthy b/c usually viral in etiology)
 If increased sputum purulence, sputum volume, increased dyspnea  YES ABX
 If on mechanical ventilation  YES ABX
 If fail outpatient therapy  hospital admission
- Acute Asthma Exacerbation
o ** (viral URI is common trigger)
o Clues:
 SOB, wheezing, coughing, drop in peak expiratory flow >20%
o FSOM: - SABA (albuterol) --- followed by systemic corticosteroids (Prednisone)
 Inhaled short-acting bronchodilators
 (SABA - albuterol)
 If symptoms persist  Systemic corticosteroids
 Prednisone 40mg daily – 5-10 days
o Shown to decrease asthma symptom relapse, SABA, and rate of
hospitalization
o What requires Hospital Admission?
 Severe asthma exacerbation
 Hypoxemia, difficulty speaking, use of accessory muscles, reduction in
peak expiratory flow > 50% from baseline
 If these symptoms present, should receive immediate emergency care
o WRONG ANSWERS
 No CXR
 Not needed for asthma exacerbation
 ** Unless evidence of concurrent PNA
o Eg. Fever, chest pain, increased sputum production, crackles,
dullness to percussion
 No Abx
 For COPD exacerbation w/ sputum and dyspnea
 Inhaled corticosteroids
 Used for chronic management of persistent asthma
 Not for acute management
 LABAs
 Used for chronic management, and only in combination w/ inhaled
corticosteroids
 No role for acute management
- Pancreatitis
o Most frequent single-item predictors of severity
 HCT >44% on admission
 Greater hemoconcentration from 3rd space losses
 BUN >20 on admission
 Increased risk of death
 ** Increases in BUN on serial measurements also associated with worse
outcomes
 AST > 250
 BMI >30
 Serum lipase > 1000 in adults (In children > 7 times upper limit of normal)
 ** Not triglyceride >1000
  associated with increased risk of acute pancreatitis, NOT disease
severity
o Ranson Criteria vs APACHE II score
 Ranson criteria, involves 11 different criteria (some of which cannot be
calculated until 48 hrs after admission)
 Shown to be poor predictor of severity
o APACHE II
 Improved predictive characteristics
o SIRS and BISAP (Bedside index for severity in AP)
 Also better than Ranson

- Afib w/ RVR
o Tx:
 1st: Rate-control
 BB or CCB
o BB --- Metoprolol or Atenolol
o CCB --- Diltiazem or Verapamil
o Rate-control improved ventricular filling  increases cardiac
output
o Goal: HR< 110
 ** Not for decompensated HF, hypotension, or bradyarrhythmias
 Because they have negative inotropic effects
- Biliary Colic
o Confirmed cholelithiasis on US
 Tx: Pain management and prophylactic, elective cholecystectomy
 Poor surgical candidate?  UDCA (Ursodeoxycholic acid)
- Meningococcal meningitis --- (antibiotic chemoprophylaxis)
o Which contacts requires antibiotic prophylaxis for meningococcal meningitis?
 Anyone w/ exposure to respiratory secretions
 Household contacts, person who intubates him, close contacts, child
care workers, person near patient >8hrs (eg airline traveler)
o What is the recommended antibiotic for meningococcal chemophophylaxis for close
contacts?
 Rifampin (4 doses orally)
 Pregnant?  Ceftraxone
 (Other options:  Cipro or IM ceftriaxone)
o Notes: Neisseria meningitidis acute bacterial meningitis
 Adolescents 2-18
 Nasopharyngeal epithelium
- HIV associated lipodystrophy vs adrenal hyperplasia / Cushing syndome
o Both have central humps and increased visceral fat…but w/ adrenal hyperplasia -->
there are other symptoms (proximal muscle weakness, facial plethora, easy bruising,
abdominal striae
 HIV associated lipodystrophy is associated w/ insulin resistance & dyslipidemia
- Tx for HIV patient w/ dyslipidemia  statin (ator, rosu, or prava)

- When to use Gemfibrozil (fibrates)


o Only to reduce risk of pancreatitis w/ triglycerides levels > 886
o ** Reduction of triglyceride s has not been shown to reduce CV risk
- Primary HIV infection VS infectious mononucleosis
o Both have unexplained, fever, fatigue, weight loss, LAD
 Exudative pharyngitis  Mono (** won’t see pharyngeal exudate w/ HIV)
 Diarrhea / rash HIV
- Mono (Epstein Barr)
o Tx: Supportive Care (NSAIDs)
 ** Acyclovir ONLY in immunocompromised patients
 ** Oral /IV prednisone ONLY for severe tonsillar enlargement w/ concern for
airway obstruction
- Rapid sequence intubation
o IV etomidate, succinylcholine, endotracheal intubation
 Rapidly acting sedative (etomidate, propofol, midazolam
 Paralytic (succinylcholine, rocuronium)

- EKG findings of PE
o New R bundle branch block (2/2 RV strain)
o Q waves and ST segment changes in the inferior leads
- Echo findings of PE
o Moderate Tricuspid Valve Regurgitation (w/ dilation of tricuspid valve annulus)
o RV dysfunction, decreased contractility, presence of RV thrombus

- When to use antiviral (Oseltamivir) for influenza?


o Patient’s who require hospitalization, severe progressive disease, underlying high-risk
medical conditions
o ** NEVER Adamantane / Rimantadine – high levels of resistance in US

- The best diagnostic test for esophageal perforation (Boerhaave Syndrome)


o esophagogram with water-soluble contrast (diatrizoate)
o CT scan of the chest is helpful but may not detect small tears or ruptures.
o Upper gastrointestinal endoscopy may worsen pneumomediastinum and should
generally be avoided in patients with suspected Boerhaave syndrome.
o This test provides a definitive diagnosis in 90% of cases. If the test is negative but
clinical suspicion is high, barium contrast can be used. Water-soluble contrast is
preferred as barium can produce further mediastinal irritation and injury in patients
with Boerhaave syndrome.
- Biliary Colic vs Acute Cholecystitis
o Both:
 RUQ pain, nausea vomiting
o Acute Chole
 PERSISTENT RUQ pain (>6hrs), leukocytosis, fever
 GB wall thickening, +PCF, sonographic murphy sign
o Biliary Colic
 TRANSIENT RUQ (<6hrs)
- Esmolol is an ultra-short acting beta-blocker that is used for rate control in patients with rapid
atrial flutter or fibrillation. It is not indicated in patients with PSVT.

You might also like